Sarcoma 180 weight, DNA, and protein increase, depending on ARA-C schedule.
D000284:Administration, Oral; D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D007274:Injections, Intraperitoneal; D051379:Mice; D009363:Neoplasm Proteins / Q000032:analysis; D012510:Sarcoma 180 / Q000032:analysis / Q000188:drug therapy*
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D003561:Cytarabine